Compare Liquidia Corporation Common Stock (LQDA) vs MasterCard Inc (MA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs MasterCard Inc — how do they compare? Liquidia Corporation Common Stock trades at $34.9 (market cap $2.40B), while MasterCard Inc trades at $607.5 (market cap $529.81B). The key difference: MasterCard Inc is far larger — about 220.8× Liquidia Corporation Common Stock's market cap, and MasterCard Inc pays a 0.58% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and MasterCard Inc for 135 Days on average.
| LQDA | MA | |
|---|---|---|
Market Cap | $2.40B | $529.81B |
Volume | 2,857,547 | 3,710,695 |
Sector | Health | Financials |
52-Week High | $91.03 | $604.80 |
52-Week Low | $22.02 | $471.55 |
Typical Hold Time | 0 Days | 135 Days |
Enterprise Value | $2.30B | $542.84B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Mastercard (MA) trades at $603.24, up 1.37% on the day, with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with consistent revenue growth from $22.2B in 2022 to $32.8B in 2025, net income margins above 45%, and three consecutive quarterly earnings beats. Institutional buying activity remains strong, with multiple funds increasing positions in Q4 2025.
Outlook remains positive with 80% analyst buy ratings and $668.67 consensus price target, representing 11% upside. Key risks include payment industry disruption from stablecoins and AI-driven competitors, though Mastercard's aggressive innovation strategy and expanding digital inclusion initiatives provide growth catalysts. The stock trades near resistance at $603 with support at $591.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →
